Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops microchips for the delivery of drugs and other chemicals.
Year Established: | 1999 |
Funding: | |
Address: | Bedford, MA 01730 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | 781-275-1446 |
Mail: | |
Company URL: | http://www.mchips.com |
Career Opportunities
MicroCHIPS
Press Releases
October 14 2008
Â
MicroCHIPS Names Tamborlane to New Scientific Advisory Board
-->
January 7 2010
Â
MicroCHIPS Advances Platform for Monitoring and Therapy Solutions
December 3 2009
Â
MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
January 6 2009
Â
MicroCHIPS Names Osteoporosis Expert Robert M. Neer to Advisory Board
November 17 2008
Â
MicroCHIPS Awarded AAPS 2008 Drug Delivery Technology Award
October 14 2008
Â
MicroCHIPS CEO Named in Popular Scienceâs âSeventh Annual Brilliant 10â
September 24 2008
Â
MicroCHIPS Names William V. Tamborlane MD to New Scientific Advisory Board
October 23 2007
Â
MicroCHIPS Hires Industry Veteran Robert Farra to Lead Diabetes and Drug Delivery Product Programs
April 3 2007
Â
MicroCHIPS Receives Equity Investment from Leading Pharmaceutical Company
March 13 2006
Â
Scientists Use Wireless Microchips to Control Drug Release In Vivo
Publications
Inc. Magazine December 4 2009
Â
Reengineering the Human Body
Mass High Tech March 13 2009
Â
Retracing a medical devices discovery-to-market process
Small Times Magazine March/April 2008
Â
A Slow Road to Big Impact: Small Tech in Medicine
Pharmaceutical Research February 12 2008
Â
Long-term Stability and In Vitro Release of hPTH(1
Flybridge Capital Partners (FKA: IDG Ventures Boston),Polaris Venture Partners
Ajit S. Gill President & Chief Executive Officer Ajit Gill is a medical industry veteran with experience developing and commercializing biopharmaceutical products, creating successful partnerships, raising funds, and growing companies from start-ups to publicly traded firms. During his fourteen year tenure at Nektar Therapeutics, the company developed a leading drug delivery technology portfolio, completed over 30 strategic alliances with biopharmaceutical partners, and commercialized products with these partners that account for over $4.5 billion in sales. Since leaving Nektar, Mr. Gill has served as CEO of Auspex Pharmaceuticals and as Entrepreneur-in-Residence for US Venture Partners of Menlo Park, California. Earlier in his career he held a variety of roles including general management, finance, business development and operations in the computer and other industries. Originally from India, Mr. Gill completed his B. Tech in electrical engineering from the Indian Institute of Technology, Kanpur, his MS in electrical engineering from the University of Nebraska and his MBA from the University of Western Ontario.
Robert W. Crane Chief Financial Officer Robert Crane is a seasoned executive with strong general management and financial experience who has had involvement at all levels in the starting, building, turnaround and financing of healthcare companies. Bob has extensive experience with public and private companies, corporate partnerships in the U.S. as well as Europe and Japan, fundraising both private and public, sale of companies and product lines as well as the acquisition of companies and technologies. He has been the CFO of several successful healthcare companies as well as a venture capitalist. He earned his MBA from Stanford and his Bachelors from MIT.
Robert Farra Vice President, Research and Development Robert Farra has over two decades of leadership experience successfully developing complex electro-mechanical medical devices. Most recently, he served as Vice President of Engineering and Manufacturing for Abiomed, leading the development of intra-aortic balloon pumps and ventricular assist devices. Mr. Farra has also held leadership positions at Accellent Endoscopy and Arthur D. Little, Inc. (ADL) where he led multidisciplinary teams in the development of numerous minimally invasive surgical instruments and interventional devices. Mr. Farra holds a BSME from University of Massachusetts, Lowell and an SMME from MIT. Mr. Farra holds nine domestic and international patents.
Maggie Pax Vice President of Business Development Maggie Pax is an experienced medical device executive with a track record of new business creation and market development for innovative medical technologies. At Hewlett-Packard Medical Products Group (now Philips Medical Systems), Maggie held senior roles in marketing, strategic business planning and corporate partnering. As Vice President of Marketing for OmniSonics Medical Technologies, Maggie led market development, product launch, post-market clinical studies and strategic product planning for the company's novel therapeutic peripheral vascular device business. Maggie earned an MBA from Harvard Business School and her Bachelors from the College of the Holy Cross.